NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $678,799 | +2.3% | 6,664 | +1.3% | 0.05% | +6.4% |
| Q2 2023 | $663,689 | +11.7% | 6,577 | +1.9% | 0.05% | +11.9% |
| Q1 2023 | $593,956 | -3.1% | 6,456 | -4.5% | 0.04% | -10.6% |
| Q4 2022 | $613,178 | +25.9% | 6,759 | +5.5% | 0.05% | +14.6% |
| Q3 2022 | $487,000 | -4.1% | 6,404 | +6.5% | 0.04% | 0.0% |
| Q2 2022 | $508,000 | -4.7% | 6,013 | -1.0% | 0.04% | +13.9% |
| Q1 2022 | $533,000 | -0.4% | 6,075 | -0.7% | 0.04% | +2.9% |
| Q4 2021 | $535,000 | +7.4% | 6,118 | +0.4% | 0.04% | -2.8% |
| Q3 2021 | $498,000 | -2.7% | 6,091 | +8.5% | 0.04% | -10.0% |
| Q2 2021 | $512,000 | +71.2% | 5,612 | +60.4% | 0.04% | +37.9% |
| Q1 2021 | $299,000 | -12.3% | 3,498 | -3.0% | 0.03% | -17.1% |
| Q4 2020 | $341,000 | -45.9% | 3,607 | -50.2% | 0.04% | -27.1% |
| Q3 2020 | $630,000 | +76.5% | 7,242 | +92.4% | 0.05% | +6.7% |
| Q4 2019 | $357,000 | – | 3,765 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |